Related Experiment Video
Updated: May 31, 2026
Generation and Purification of Human INO80 Chromatin Remodeling Complexes and Subcomplexes
Published on: October 23, 2014
Optimization of transfection efficiency of small interfering RNA in purified human prolactinoma cells
Qing-Hu Meng1, Yong-Mei Song, Jiang Zhao
1Department of Neurosurgery, Beijing Sanbo Brain Hospital of the Capital Medical University, Beijing 100093, China.
Background:
Control of hypersecretion of certain hormones is one of the key targets in the treatment of pituitary adenomas. RNA interference has been shown to inhibit protein expression, and thus it may represent a promising method for the treatment of pituitary adenomas. In the present study, transfection efficiency of small interfering RNA (siRNA) was optimized in human prolactinoma cells.
Methods:
First, a method was optimized to extract highly purified human prolactinoma cells in vitro. The extracted cells were verified to retain the physiological features of prolactin (PRL) secretion. Second, three conditions for siRNA transfection were tested by the evaluation of transfection efficiency and cell viability. The proper transfection condition was verified for human prolactinoma cells. Third, the siRNA for prolactin was transfected into the human prolactinoma cells, and the suppression of PRL mRNA was evaluated by quantitative real-time reverse transcription-PCR.
Results:
The siRNA of 100 pmol with Lipofectamine 2000 of 5 µl for 1 × 10(6) cells was proved preferable, with transfection efficiency being 53.3% and cell viability being 69.7%. In the preliminary experiment the siRNA against PRL decreased the mRNA of PRL by 34.0%.
Conclusion:
It is possible to inhibit hormone hypersecretion by RNA interference, that may eventually enable therapeutic siRNA drugs developed.
Insights
This study optimized small interfering RNA (siRNA) delivery in human prolactinoma cells. RNA interference successfully reduced prolactin messenger RNA, showing potential for treating hormone hypersecretion in pituitary adenomas.
Area of Science:
- Endocrinology
- Molecular Biology
- Gene Therapy
Background:
- Pituitary adenomas often cause hormone hypersecretion, necessitating targeted treatments.
- RNA interference (RNAi) offers a potential therapeutic strategy by inhibiting specific protein expression.
- Optimizing small interfering RNA (siRNA) delivery is crucial for its clinical application in pituitary adenoma treatment.
Purpose of the Study:
- To optimize the transfection efficiency of siRNA in human prolactinoma cells.
- To evaluate the efficacy of siRNA in suppressing prolactin (PRL) mRNA levels.
Main Methods:
- Developed a method for isolating and verifying functional human prolactinoma cells in vitro.
- Tested and optimized three siRNA transfection conditions, assessing transfection efficiency and cell viability.
- Quantified PRL mRNA reduction using quantitative real-time reverse transcription-PCR after siRNA transfection.
Main Results:
- Identified optimal conditions: 100 pmol siRNA with 5 µl Lipofectamine 2000 for 1 × 10(6) cells, achieving 53.3% transfection efficiency and 69.7% cell viability.
- Demonstrated a 34.0% reduction in PRL mRNA levels in preliminary experiments using siRNA targeting PRL.
Conclusions:
- RNA interference is a viable method for inhibiting hormone hypersecretion in pituitary adenomas.
- Further development of siRNA-based therapeutics holds promise for treating pituitary adenomas.
